ATXS insider transaction filings
Astria Therapeutics, Inc. — 46 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-01-23. Screen ATXS transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ATXS between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Astria Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-23 | 4 | Violin Jonathan — Director | Disposition to issuer (D): 263,321 · Disposition to issuer (D): 14,166 (derivative) · Disposition to issuer (D): 8,333 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 26,550 (derivative) | EDGAR |
| 2026-01-23 | 4 | Morabito Christopher — Chief Medical Officer | Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 262,500 (derivative) | EDGAR |
| 2026-01-23 | 4 | Milne Jill C. — CEO and President, Director | Disposition to issuer (D): 4,377 · Disposition to issuer (D): 195,000 (derivative) · Disposition to issuer (D): 761,000 (derivative) | EDGAR |
| 2026-01-23 | 4 | Matthews Andrea — Chief Business Officer | Disposition to issuer (D): 32,812 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 262,500 (derivative) | EDGAR |
| 2026-01-23 | 4 | Komjathy Andrew — Chief Commercial Officer | Disposition to issuer (D): 10 · Disposition to issuer (D): 45 · Disposition to issuer (D): 45 · Disposition to issuer (D): 55,000 (derivative) · Disposition to issuer (D): 225,000 (derivative) | EDGAR |
| 2026-01-23 | 4 | Harshbarger Benjamin — Chief Legal Officer | Disposition to issuer (D): 33,333 (derivative) · Disposition to issuer (D): 55,000 (derivative) · Disposition to issuer (D): 262,500 (derivative) | EDGAR |
| 2026-01-23 | 4 | Cole Hugh M — Director | Disposition to issuer (D): 16,666 (derivative) · Disposition to issuer (D): 8,333 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 26,550 (derivative) | EDGAR |
| 2026-01-23 | 4 | Clauser Noah — Chief Financial Officer | Disposition to issuer (D): 55,000 (derivative) · Disposition to issuer (D): 262,500 (derivative) | EDGAR |
| 2026-01-23 | 4 | Callori Fred — Director | Disposition to issuer (D): 14,166 (derivative) · Disposition to issuer (D): 8,333 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 26,550 (derivative) | EDGAR |
| 2026-01-23 | 4 | Beck Joanne T. — Director | Disposition to issuer (D): 16,666 (derivative) · Disposition to issuer (D): 8,333 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 26,550 (derivative) | EDGAR |
| 2026-01-23 | 4 | AGARWAL SUNIL — Director | Disposition to issuer (D): 28,200 (derivative) · Disposition to issuer (D): 26,550 (derivative) | EDGAR |
| 2026-01-23 | 4 | LAPOINTE ANTHONY GREGG — Director | Disposition to issuer (D): 16,666 (derivative) · Disposition to issuer (D): 8,333 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 26,550 (derivative) | EDGAR |
| 2026-01-23 | 4 | BATE KENNETH — Director | Disposition to issuer (D): 16,666 (derivative) · Disposition to issuer (D): 8,333 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 26,550 (derivative) | EDGAR |
| 2026-01-23 | 4 | KISHBAUCH MICHAEL D — Director | Disposition to issuer (D): 16,666 (derivative) · Disposition to issuer (D): 8,333 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 26,550 (derivative) | EDGAR |
| 2025-06-12 | 4 | AGARWAL SUNIL — Director | Grant/award (A): 26,550 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Cole Hugh M — Director | Grant/award (A): 26,550 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Violin Jonathan — Director | Grant/award (A): 26,550 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Beck Joanne T. — Director | Grant/award (A): 26,550 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Callori Fred — Director | Grant/award (A): 26,550 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | LAPOINTE ANTHONY GREGG — Director | Grant/award (A): 26,550 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | BATE KENNETH — Director | Grant/award (A): 26,550 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | KISHBAUCH MICHAEL D — Director | Grant/award (A): 26,550 (derivative) @ $0 | EDGAR |
| 2025-03-25 | 4 | Milne Jill C. — CEO and President, Director | Grant/award (A): 761,000 (derivative) @ $0 | EDGAR |
| 2025-03-25 | 4 | Matthews Andrea — Chief Business Officer | Grant/award (A): 262,500 (derivative) @ $0 | EDGAR |
| 2025-03-25 | 4 | Komjathy Andrew — Chief Commercial Officer | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-03-25 | 4 | Harshbarger Benjamin — Chief Legal Officer | Grant/award (A): 262,500 (derivative) @ $0 | EDGAR |
| 2025-03-25 | 4 | Clauser Noah — Chief Financial Officer | Grant/award (A): 262,500 (derivative) @ $0 | EDGAR |
| 2025-03-25 | 4 | Morabito Christopher — Chief Medical Officer | Grant/award (A): 262,500 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Beck Joanne T. — Director | Grant/award (A): 14,100 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Violin Jonathan — Director | Grant/award (A): 14,100 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Callori Fred — Director | Grant/award (A): 14,100 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Cole Hugh M — Director | Grant/award (A): 14,100 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | LAPOINTE ANTHONY GREGG — Director | Grant/award (A): 14,100 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | BATE KENNETH — Director | Grant/award (A): 14,100 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | KISHBAUCH MICHAEL D — Director | Grant/award (A): 14,100 (derivative) @ $0 | EDGAR |
| 2024-04-09 | 4 | AGARWAL SUNIL — Director | Grant/award (A): 28,200 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Morabito Christopher — Chief Medical Officer | Option exercise (M): 10,000 @ $3.87 · Sale (S): 10,000 @ $13.59 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Morabito Christopher — Chief Medical Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Milne Jill C. — CEO and President, Director | Grant/award (A): 534,600 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Matthews Andrea — Chief Business Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Komjathy Andrew — Chief Commercial Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Harshbarger Benjamin — Chief Legal Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Clauser Noah — Chief Financial Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | PERCEPTIVE ADVISORS LLC — Director PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director Perceptive Xontogeny Venture Fund, LP — Director EDELMAN JOSEPH — Director | Purchase (P): 2,481,350 @ $12.09 | EDGAR |
| 2024-01-30 | 4 | Morabito Christopher — Chief Medical Officer | Option exercise (M): 800 @ $3.87 · Sale (S): 800 @ $11.02 · Option exercise (M): 9,200 @ $3.87 · Sale (S): 9,200 @ $11.15 · Option exercise (M): 800 (derivative) @ $0 · Option exercise (M): 9,200 (derivative) @ $0 | EDGAR |
| 2023-12-22 | 4 | PERCEPTIVE ADVISORS LLC — Director PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director Perceptive Xontogeny Venture Fund, LP — Director EDELMAN JOSEPH — Director | Purchase (P): 740,000 @ $6.20 | EDGAR |
Recent 8-K events — Astria Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-01-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-03-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-13 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ATXS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →